IAN Stock Overview
Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
iAnthus Capital Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.045 |
| 52 Week Low | CA$0.005 |
| Beta | 0.72 |
| 1 Month Change | -50.00% |
| 3 Month Change | -66.67% |
| 1 Year Change | -85.71% |
| 3 Year Change | -96.43% |
| 5 Year Change | -99.71% |
| Change since IPO | -99.66% |
Recent News & Updates
The Market Doesn't Like What It Sees From iAnthus Capital Holdings, Inc.'s (CSE:IAN) Revenues Yet As Shares Tumble 33%
Nov 03
Improved Revenues Required Before iAnthus Capital Holdings, Inc. (CSE:IAN) Stock's 33% Jump Looks Justified
Sep 10Benign Growth For iAnthus Capital Holdings, Inc. (CSE:IAN) Underpins Stock's 40% Plummet
Jul 26Recent updates
The Market Doesn't Like What It Sees From iAnthus Capital Holdings, Inc.'s (CSE:IAN) Revenues Yet As Shares Tumble 33%
Nov 03Improved Revenues Required Before iAnthus Capital Holdings, Inc. (CSE:IAN) Stock's 33% Jump Looks Justified
Sep 10Benign Growth For iAnthus Capital Holdings, Inc. (CSE:IAN) Underpins Stock's 40% Plummet
Jul 26iAnthus Capital Holdings, Inc. (CSE:IAN) Stock Catapults 50% Though Its Price And Business Still Lag The Industry
May 05iAnthus Capital Holdings, Inc. (CSE:IAN) Stocks Pounded By 29% But Not Lagging Industry On Growth Or Pricing
Feb 29iAnthus Capital Holdings, Inc. (CSE:IAN) Stock's 33% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Apr 17Is iAnthus Capital Holdings (CSE:IAN) Using Debt Sensibly?
Feb 28Is iAnthus Capital Holdings (CSE:IAN) A Risky Investment?
Aug 25Shareholder Returns
| IAN | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -0.5% | -2.6% |
| 1Y | -85.7% | -26.9% | 15.2% |
Return vs Industry: IAN underperformed the Canadian Pharmaceuticals industry which returned -26.9% over the past year.
Return vs Market: IAN underperformed the Canadian Market which returned 15.2% over the past year.
Price Volatility
| IAN volatility | |
|---|---|
| IAN Average Weekly Movement | 71.1% |
| Pharmaceuticals Industry Average Movement | 12.0% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CA Market | 17.3% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: IAN's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: IAN's weekly volatility has increased from 49% to 71% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 760 | Richie Proud | www.ianthus.com |
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers cannabis flower and trims, such as packaged flowers and pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products.
iAnthus Capital Holdings, Inc. Fundamentals Summary
| IAN fundamental statistics | |
|---|---|
| Market cap | CA$33.37m |
| Earnings (TTM) | -CA$77.78m |
| Revenue (TTM) | CA$237.01m |
0.1x
P/S Ratio-0.4x
P/E RatioIs IAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IAN income statement (TTM) | |
|---|---|
| Revenue | US$164.93m |
| Cost of Revenue | US$93.03m |
| Gross Profit | US$71.89m |
| Other Expenses | US$126.02m |
| Earnings | -US$54.12m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0081 |
| Gross Margin | 43.59% |
| Net Profit Margin | -32.82% |
| Debt/Equity Ratio | -189.6% |
How did IAN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:37 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
iAnthus Capital Holdings, Inc. is covered by 10 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Stanley | Beacon Securities Limited |
| Nikolaas Faes | Bryan Garnier & Co |
| null null | Canaccord Genuity |